KTTAW · Pasithea Therapeutics Corp.
$0.01
+0.00 (+1.35%)
At close · Aug 25
Market Cap
$19.01M
Shares
33.41M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$486.56K
+3130.4%
FY2022
Net Income
-$20.43M
-46.9%
FY2025
Gross Margin
-14.69%
FY2021
Operating Margin
-2587.35%
+27338.4pp
FY2022
Diluted EPS
-$2.91
+77.1%
FY2025
Operating Cash Flow
-$15.21M
-9.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| — | — | — | — | $486.56K | $15.06K | |
| — | — | — | — | — | -$508 | |
| — | — | — | — | $113.2K | $17.28K | |
| — | — | — | — | — | -$2213 | |
| — | — | — | — | — | -14.69% | |
| $10.73M | $7.98M | $7.2M | $8.1M | $2.67M | — | |
| $13.23M | $12.88M | $7.05M | — | — | — | |
| — | — | $7.05M | $7.88M | $9.92M | $4.51M | |
| — | — | — | — | $697.12K | $1.31M | |
| -$23.96M | -$20.86M | -$14.25M | -$15.98M | -$12.59M | -$4.51M | |
| — | — | — | — | -2587.35% | -29925.73% | |
| — | — | — | — | $102 | $508 | |
| $2.66M | $429.61K | $345.38K | $471.61K | $861.09K | $2.33M | |
| -$21.29M | -$20.43M | -$13.9M | -$15.51M | -$11.73M | -$2.17M | |
| -$21.29M | -$20.43M | -$13.9M | -$15.96M | -$13.94M | -$2.17M | |
| — | — | — | — | -2864.29% | -14430.49% | |
| -$21.27M | -$20.41M | -$13.91M | -$15.97M | -$13.93M | -$2.18M | |
| USD/shares | — | -$2.91 | -$12.69 | -$0.42 | -$1.76 | -$4.20 |
| USD/shares | — | -$2.91 | -$12.69 | -$0.42 | -$1.76 | -$4.20 |
| shares | — | 7.03M | 1.1M | 1.23M | 1.26M | 520.23K |
| shares | — | 7.03M | 1.1M | 1.23M | 1.26M | 520.23K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2022 | FY2021 |
|---|---|---|
| Clinics 1 | $486,559 | $15,062 |
Key facts
CIK
1841330
CUSIP
70261F202
13F (30d)
32 filings
31 filers
Visit website
Investor relations